Vanguard Group Inc Amneal Pharmaceuticals, Inc. Put Options Transaction History
Vanguard Group Inc
- $6.44 Trillion
- Q3 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AMRX
# of Institutions
259Shares Held
150MCall Options Held
357KPut Options Held
0-
Rubric Capital Management LP New York, NY12.3MShares$144 Million2.03% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$144 Million7.99% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$131 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il5.73MShares$66.7 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX5.43MShares$63.2 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.76B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...